Government drug pricing policy threatening pharmaceutical industry

Published: 2008-11-19 07:00:00

Updated: 2008-11-19 07:00:00

The recent decision by the Health Insurance Review and Assessment Service (HIRA) to evaluate the cost-effectiveness of cholesterol-lowering medicines based on individual products instead of active ingredients is putting bigger pressure on local pharmaceutical firms, which have focused on cheap generic products.

According to industry sources, the HIRA unexpectedly decided to recognize better ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.